Shell Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2M Sell
4,691
-9,691
-67% -$3.76M 0.2% 106
2025
Q2
$5.51M Buy
14,382
+4,081
+40% +$1.47M 0.19% 109
2025
Q1
$3.56M Sell
10,301
-459
-4% -$148K 0.17% 120
2024
Q4
$3.23M Sell
10,760
-126
-1% -$44K 0.14% 138
2024
Q3
$4.42M Buy
+10,886
New +$3.99M 0.19% 100
2024
Q1
$3.54M Buy
11,015
+1,526
+16% +$466K 0.16% 118
2023
Q4
$2.57M Sell
9,489
-2,498
-21% -$617K 0.12% 181
2023
Q3
$2.95M Sell
11,987
-168
-1% -$46K 0.12% 174
2023
Q2
$3.69M Buy
12,155
+8
+0.1% +$2.22K 0.15% 151
2023
Q1
$3.2M Sell
12,147
-35
-0.3% -$8.89K 0.13% 164
2022
Q4
$2.92M Buy
12,182
+1,048
+9% +$235K 0.13% 171
2022
Q3
$2.05M Sell
11,134
-3,119
-22% -$621K 0.08% 243
2022
Q2
$2.4M Buy
14,253
+173
+1% +$37.2K 0.07% 267
2022
Q1
$3.53M Buy
14,080
+245
+2% +$61.5K 0.08% 237
2021
Q4
$3.55M Buy
13,835
+4,908
+55% +$1.2M 0.07% 255
2021
Q3
$2.17M Buy
8,927
+194
+2% +$47.4K 0.05% 317
2021
Q2
$1.8M Buy
8,733
+17
+0.2% +$3.46K 0.04% 383
2021
Q1
$1.64M Sell
8,716
-3,114
-26% -$549K 0.03% 394
2020
Q4
$1.95M Buy
11,830
+3,567
+43% +$522K 0.04% 389
2020
Q3
$1.03M Buy
8,263
+122
+1% +$15.1K 0.02% 449
2020
Q2
$790K Sell
8,141
-3,965
-33% -$412K 0.02% 504
2020
Q1
$1.09M Sell
12,106
-1,100
-8% -$142K 0.03% 409
2019
Q4
$1.95M Sell
13,206
-23,853
-64% -$3.2M 0.04% 369
2019
Q3
$4.46M Sell
37,059
-2,573
-6% -$333K 0.1% 233
2019
Q2
$5.36M Sell
39,632
-1,800
-4% -$228K 0.12% 208
2019
Q1
$5.4M Sell
41,432
-9,726
-19% -$1.31M 0.12% 214
2018
Q4
$6.37M Sell
51,158
-952
-2% -$128K 0.16% 168
2018
Q3
$7.25M Sell
52,110
-1,086
-2% -$135K 0.14% 172
2018
Q2
$5.46M Sell
53,196
-9,181
-15% -$929K 0.11% 226
2018
Q1
$6.05M Hold
62,377
0.12% 209
2017
Q4
$5.48M Buy
62,377
+8,639
+16% +$694K 0.11% 218
2017
Q3
$4.28M Sell
53,738
-7,317
-12% -$588K 0.1% 240
2017
Q2
$5.32M Buy
61,055
+16,462
+37% +$1.39M 0.11% 217
2017
Q1
$3.97M Buy
44,593
+3,028
+7% +$252K 0.09% 248
2016
Q4
$3.08M Buy
41,565
+4,118
+11% +$308K 0.07% 287
2016
Q3
$2.83M Buy
37,447
+361
+1% +$27.6K 0.06% 327
2016
Q2
$2.86M Buy
37,086
+19,984
+117% +$1.58M 0.07% 298
2016
Q1
$1.33M Buy
17,102
+513
+3% +$35.8K 0.03% 481
2015
Q4
$1.12M Sell
16,589
-34,933
-68% -$2.44M 0.03% 518
2015
Q3
$3.63M Sell
51,522
-9,853
-16% -$872K 0.06% 285
2015
Q2
$5.57M Buy
61,375
+34,264
+126% +$2.75M 0.11% 198
2015
Q1
$2.04M Sell
27,111
-14,010
-34% -$1.01M 0.04% 458
2014
Q4
$3.02M Sell
41,121
-10,401
-20% -$731K 0.05% 356
2014
Q3
$3.63M Sell
51,522
-488
-0.9% -$32.3K 0.06% 295
2014
Q2
$2.93M Sell
52,010
-2,615
-5% -$138K 0.05% 355
2014
Q1
$2.87M Buy
54,625
+5,280
+11% +$263K 0.05% 359
2013
Q4
$2.35M Sell
49,345
-14,141
-22% -$654K 0.04% 435
2013
Q3
$2.71M Sell
63,486
-8,480
-12% -$331K 0.05% 384
2013
Q2
$2.6M Buy
+71,966
New +$2.78M 0.05% 388

Other funds holding HCA

Shell Asset Management's HCA Position: Q3 2025 in Review

Shell Asset Management reduced its HCA Healthcare (HCA) stake by 67% in Q3 2025, selling an estimated $3.76M and leaving 4,691 shares worth $2M. The position accounts for 0.2% of the portfolio, ranked #106.

Shell Asset Management first reported a position in HCA in Q2 2013 and has held it in 49 quarters since. The position peaked at $7.25M in Q3 2018. 1,287 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

  • Shell Asset Management held 4,691 shares of HCA Healthcare worth $2M as of Q3 2025.
  • Shell Asset Management sold 9,691 HCA Healthcare shares in Q3 2025, an estimated $3.76M.
  • HCA Healthcare made up 0.2% of Shell Asset Management's portfolio in Q3 2025, its #106 holding.
  • Shell Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 49 quarters since.
  • Shell Asset Management's HCA Healthcare position peaked at $7.25M in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.